STATUS EPILEPTICUS ASSOCIATED WITH PLATINUM CHEMOTHERAPY IN A PATIENT WITH CERVICAL CANCER: A CASE REPORT
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: A case r...":
Laura L. Holman 1 , Yulan Ren 2 and Shannon N. Westin 1* Abstract Background: While peripheral neuropathy is a common side effect of platinum-based chemotherapy, central nervous system (CNS) toxicity, such as encephalopathy or seizures, appears to be rare. This manuscript de[r]
CAS E REP O R T Open AccessComplete response to FOLFOX4 therapy in apatient with advanced urothelial cancer: a casereportYu Ri Seo1, Se Hyung Kim1, Hyun Jung Kim1, Chan Kyu Kim1, Seong Kyu Park1, Eun Suk Koh2, Dae Sik Hong1*AbstractNo standard has been established for sal[r]
CAS E REP O R T Open AccessThe role of perfusion CT in identifying strokemimics in the emergency room: a case of statusepilepticus presenting with perfusion CTalterationsWaldo R Guerrero*, Haitham Dababneh and Stephan EisenschenkAbstractEmergency medicine physician[r]
LFH involving the ul nar, radia l, sciatic and plantarnerves [3,5-7]. LFH is considered to be congenital inorigin and has been commonly associated with macro-dactyly and other conditions at birth. The surgical man-agement remains controversial with some authorsrecommending decom[r]
Hypereosinophilia, defined by an absolute eosinophil count of more than 1500/mm3, is rarely observed in patients treated for cancer, and rarely imputable to anti-cancer agents. Drug-induced hypereosinophilia usually appears within a few weeks of the start of treatment and resolves after discontinuat[r]
fibrofatty elements infiltrating the perineurium withmature fibrous and adipose tissue separating nerve fasci-cles. There was no neural hypertrophy. A histologicaldiagnosis of LFH was made. The postoperative periodwas unremarkable and the patient experienced acomplete resolution of his[r]
Although a definitive conclusion on the clinical significance of response shift cannot be drawn from existing studies [87], interven-tions that serve to facilitate response shift for improving QoL for the surviving women and their partners are being offered, often in support groups [44].[r]
There is still a debate regarding whether regimens combining irinotecan with platinum could replace regimens combining etoposide with platinum, as first-line chemotherapy for extensive-stage small cell lung cancer (ES-SCLC).
Although Paget's disease of the bone is a relatively com-mon disease in Australia, New Zealand, North Americaand most European countries, but it has a low incidencein Scandinavia, and is extremely rare in the Japanese pop-ulation, with a prevalence of 0.15/1[r]
Malnutrition in gastrectomized patients receiving chemotherapy is associated with the susceptibility to chemotherapy-related adverse events. This study evaluated pre-operative nutritional status-related indices associated with adverse events in post-operation gastric cancer patients receiving chemot[r]
Neoadjuvant chemotherapy (NAC) using platinum and irinotecan (CPT-11) followed by radical excision has been shown to be a valid treatment for locally advanced squamous cervical cancer (SCC) patients.
The purpose of this study was to assess the efficacy and safety of cisplatin-based chemotherapy with or without bevacizumab (BEV) in Chinese women with advanced cervical cancer (ACC).
To report the results of combined chemoradiation (CCRT) with cisplatin versus carboplatin in locally advanced cervical carcinoma. Carboplatin yielded comparable results to cisplatin in concurrent chemo-radiation for locally advanced cervical cancer. In addition, carboplatin was associated with a bet[r]
Pulmonary tumor thrombotic microangiopathy (PTTM), a rare complication of advanced cancer, is histologically characterized by tumor embolisms and fibrocellular intimal proliferation of small pulmonary arteries and arterioles. PTTM usually has an extremely poor prognosis, and antemortem diagnosis is[r]
Antigen-processing machinery molecules play crucial roles in infectious diseases and cancers. Studies have shown that polymorphisms in endoplasmic reticulum aminopeptidase (ERAP) genes can influence the enzymatic activity of ERAP proteins and are associated with the risk of diseases.